Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma

BACKGROUND: Suppressive immune cells present in tumour microenvironments are known to augment tumour growth and hamper efficacy of antitumour therapies. The amino-bisphosphonate Zoledronic acid (ZA) is considered as an antitumour agent, as recent studies showed that ZA prolongs disease-free survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Veltman, J D, Lambers, M E H, van Nimwegen, M, Hendriks, R W, Hoogsteden, H C, Hegmans, J P J J, Aerts, J G J V
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938257/
https://www.ncbi.nlm.nih.gov/pubmed/20664588
http://dx.doi.org/10.1038/sj.bjc.6605814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938257/
https://www.ncbi.nlm.nih.gov/pubmed/20664588
http://dx.doi.org/10.1038/sj.bjc.6605814

Ejemplares similares